Flavin adenine dinucleotide (fad) for use in the prevention and/or treatment of cancer

FAD for its use according to any of the foregoing claims wherein the cancer is selected from the group consisting of breast cancer, prostate cancer, lung cancer, airway, upper and/or lower digestive tract cancer, organs of digestion cancer, kidney cancer, urinary tract cancer, genital organs cancer, skin cancer, ENT sphere cancer, and lymphatic organs cancer.

A Composition comprising FAD according to any of the foregoing claims in a therapeutically effective amount and a pharmaceutically acceptable carrier.

Composition according to the preceding claim for use in the prevention and/or treatment of cancer comprising a particle comprising a carrier and FAD at least partially encapsulated by the carrier.

Composition for its use according to the preceding claim in which the vector is chosen from at least one of metal nanoparticles including gold nanoparticles, biopolymers including Poly Ethylene Glycol (PEG), chitosan, collagen, glucose.

Composition for use according to the preceding claim wherein the FAD is covalently bonded to PEG encapsulating at least one gold atom.